Securities and Finance

NERA is widely recognized as a leading firm in the economics of securities, finance, and commerce. Our experts apply their skills in these areas to assist clients in securities and product liability litigation, commercial disputes, and risk management. We bring to bear a thorough understanding of securities, the markets in which they trade, and the regulatory institutions that govern them.

NERA economists provide answers to difficult questions arising in areas including:

  • Auction-rate securities
  • Class actions and opt-out suits involving individual securities and funds
  • Broker-customer disputes alleging unsuitability and churning
  • Subprime lending
  • Option backdating
  • Allegations of improper trading behavior by specialists or others
  • Mutual fund and brokerage fee reasonableness analyses
  • Market timing and late trading allegations in mutual funds
  • Hedge fund litigation
  • Valuations of fixed income and derivative products
  • Valuations of firms or operating entities
  • Forensic accounting, including proper application of accounting rules
  • Complex commercial disputes
  • Economic analyses of materiality, reliance, and loss causation
  • Market efficiency and tracing analyses
  • Analysis of the fairness of a proposed settlement
  • Measuring costs of illiquidity
  • Bankruptcy and fraudulent conveyance actions
  • Derivative suits
  • Insider trading and manipulation cases
  • Business valuations, including reviews of merger/acquisition due diligence
  • Mispricing and suitability issues
  • Practices such as IPO allocations and markup policies
  • Insurance litigation, including insolvencies and policyholder class actions
  • ERISA actions alleging imprudent investments
  • Employee stock option valuations
  • Supervisory goodwill litigation
  • Evaluation of risk management practices and instruments
  • Strategic consulting for exchanges and securities firms
  • Development of new financial products
  • Impact assessment of proposed regulatory changes

Our experts' knowledge spans equity and commodity markets; US government, corporate, municipal, and mortgage securities; bonds and currencies of global and emerging markets; and warrants, futures, forwards, swaps, options, and other derivatives.

Name Title Location Phone Email
Lucy P. Allen Senior Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Tsvetan Beloreshki Senior Managing Director New York City +1 212 345 5409 tsvetan.beloreshki@nera.com
Dr. Patrick Conroy Senior Managing Director Miami +1 305 341 5025 patrick.conroy@nera.com
Richard J. Eichmann Senior Managing Director
Chair of NERA's Intellectual Property Practice
San Francisco
Los Angeles
+1 415 291 1033
+1 213 346 3009
richard.eichmann@nera.com
Bradley A. Heys Senior Managing Director Toronto
New York City
+1 416 868 7312
+1 212 345 3000
brad.heys@nera.com
Dr. Vinita Juneja Senior Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice
New York City
London
Toronto
+1 212 345 3148
+44 20 7659 8618
+1 416 868 7314
vinita.juneja@nera.com
Dr. Denise Neumann Martin Senior Managing Director Miami +1 305 808 7880 denise.martin@nera.com
James Mellsop Senior Managing Director
Chair of NERA's Global Antitrust and Competition Practice
Auckland
Wellington
Sydney
+64 9 928 3290
+64 4 819 2550
+61 2 8864 6536
james.mellsop@nera.com
Dr. Faten Sabry Senior Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair
New York City
London
+1 212 345 3285
+44 20 7659 8618
faten.sabry@nera.com
Dr. David Tabak Senior Managing Director New York City +1 212 345 2176 david.tabak@nera.com
Adam Warren Senior Managing Director Chicago +1 (312) 573-2821 adam.warren@nera.com
Dr. Ling Ling Ang Managing Director Washington, DC
Chicago
+1 202 466 9259
+312 573 2827
lingling.ang@nera.com
Jorge Baez Managing Director Miami
New York City
Mexico City
+1 305 341 5060
+1 212 345 5753
+52 55 9628 7550
jorge.baez@nera.com
Dr. Jordan Milev Managing Director New York City +1 212 345 5516 jordan.milev@nera.com
Dr. Charles Parekh Managing Director Chicago +1 312 573 4809 charles.parekh@nera.com
Robert Patton Managing Director Toronto
London
New York City
+1 416 868 7318
+44 20 7659 8620
+1 212 345 3000
robert.patton@nera.com
Dr. Stephanie Plancich Managing Director New York City +1 212 345 7719 stephanie.plancich@nera.com
Mary Elizabeth C. Stern Managing Director White Plains, NY +1 914 448 4054 mary.elizabeth.stern@nera.com
Dr. Will Taylor Managing Director Auckland
Sydney
+64 9 928 3292
+61 2 8864 6535
will.taylor@nera.com
Dr. Airat Chanyshev Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Drew Claxton Director New York City +1 212 345 3442 drew.claxton@nera.com
Dr. Arturo Gonzalez Director San Francisco +1 415 291 1068 arturo.gonzalez@nera.com
Dr. Alan Grant Director Washington, DC +1 202 466 3510 alan.grant@nera.com
William P. Hrycay Director New York City +1 212 345 1518 william.hrycay@nera.com
Timothy McKenna Director Los Angeles
New York City
+1 213 346 3041
+1 212 345 3000
timothy.mckenna@nera.com
Ivelina Velikova Director New York City +1 212 345 1160 ivelina.velikova@nera.com
Dr. Tomohiko Yano Director Tokyo +81 3 6871 7045 tomohiko.yano@nera.com
Dr. Youfei Chang Senior Consultant New York City +1 (212) 3454650 youfei.chang@nera.com
Dr. Gleb Domnenko Senior Consultant New York City +1 212 345 3196 gleb.domnenko@nera.com
Edward Flores Senior Consultant New York City +1 212 345 2955 edward.flores@nera.com
Sungi Lee Senior Consultant New York City +1 212 345 8022 sungi.lee@nera.com
Jianghao Liu Senior Consultant New York City +1 212 345-3081 jianghao.liu@nera.com
Janeen McIntosh Senior Consultant New York City +1 212 345 1375 janeen.mcintosh@nera.com
Gary Napadov Senior Consultant Chicago +1 312 573 2850 gary.napadov@nera.com
David Ogilvie Senior Consultant Toronto +1 416 868 7313 david.ogilvie@nera.com
Svetlana Starykh Senior Consultant White Plains, NY +1 914 448 4123 svetlana.starykh@nera.com
Dr. Yuyao Wang Senior Consultant New York City +1 212 345 1605 yuyao.wang@nera.com
Mattia Dolci Consultant Washington, DC +1 202 466 9282 mattia.dolci@nera.com
Jielei Mao Consultant Toronto +1 416 868 7316 jielei.mao@nera.com
Dr. Dick Oosthuizen Consultant New York City +1 212 345 3133 dick.oosthuizen@nera.com
Longxuan Wang Consultant New York City +1 212 345 6048 longxuan.wang@nera.com
Dr. George Batta Affiliated Academic Los Angeles +1 213 346 3000 gbatta@cmc.edu
Dr. Michael Baye Affiliated Academic Washington, DC +1 202 466 9298 michael.baye.affiliate@nera.com
Mark L. Berenblut Affiliated Consultant Toronto
New York City
London
+1 416 868 7311
+1 917 475 0020
+44 20 3769 1096
mark.berenblut.affiliate@nera.com
Dr. Sharon Brown-Hruska Affiliated Consultant Washington, DC +1 202 466 3510 sharon.hruska.affiliate@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London
+1 212 345 5407
+44 20 7659 8500
andrew.carron.affiliate@nera.com
Dr. Alan Cox Affiliated Consultant San Francisco +1 415 291 1000 alan.cox.affiliate@nera.com
Prof. Dr. David Nickerson Affiliated Academic Washington, DC +1 202 466 3510 david.nickerson.affiliate@nera.com
Dr. James Overdahl Affiliated Industry Expert Washington, DC +1 202 547 3035 joverdahl@deltastrat.com
Dr. Paul Wertheim Affiliated Academic
Toronto
+ 1 325 674 2071
+1 416 868 7314
paul.wertheim.affiliate@nera.com
Title Type Author
The Shifting Landscape of Securities Class Action Fees Published Article Edward Flores
How Do Alternatives to LIBOR Measure Up? Published Article Dr. Faten Sabry and Ramisa Roya
Recent Trends in Securities Class Action Litigation: H1 2023 Update Report Edward Flores and Svetlana Starykh
p-Hacking and Event Studies in Securities Litigation White Paper Dr. David Tabak
Trends in Canadian Securities Class Actions: 2022 Update Published Article Bradley Heys, Robert Patton, and Jielei Mao
What Happened to SVB? Not a 2008 Repeat Story White Paper Dr. Faten Sabry, William Hrycay, and Sungi Lee
Recent Trends in Securities Class Action Litigation: 2022 Full-Year Review Report Janeen McIntosh, Svetlana Starykh, and Edward Flores
Cryptos Are Not All the Same, and the Market Knows It Published Article Faten Sabry et al.
Testing Option Market Efficiency In Securities Class Actions Published Article Edward Flores
How Will the LIBOR Transition Affect Mortgage Consumers? White Paper Dr. Faten Sabry and Ramisa Roya, et al.